Episode 24: Gadi Lachman, President and CEO, TriNetX

Episode 24 October 06, 2022 00:39:58
Episode 24: Gadi Lachman, President and CEO, TriNetX
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 24: Gadi Lachman, President and CEO, TriNetX

Oct 06 2022 | 00:39:58

/

Show Notes

Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien, welcomes Gadi Lachman, President and CEO of TriNetX, to discuss real-world solutions for accessing and refining patient data in the clinical trials industry.

Other Episodes

Episode 54

May 28, 2025 00:45:11
Episode Cover

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...

Listen

Episode 56

July 15, 2025 00:39:28
Episode Cover

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael...

Listen

Episode 13

October 27, 2021 00:50:12
Episode Cover

Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast,...

Listen